Trial NCT05069129
Publication Al Kaabi N, Nat Commun, 2022
Primary outcome on the report: 1) Neutralizing response on 15 days and 30 days after booster vaccination, by evaluation of the geometric mean titers (GMTs) of neutralizing antibodies and the corresponding fourfold rise rate (i.e., post-/pre-boost ≥4) against SARS-CoV-2 prototype strain. Neutralizing antibody titers were measured using live-virus neutralization assay;
2) Occurrence and severity of any adverse reactions within 30 days post-boost

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.